Purchase Order 75F40121P00490
Award Date 8/31/21
Potential Completion Date 8/31/26
Potential Value $50K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for preventative maintenance, corrective/remedial maintenance, and repair services for a Fortebio Octet Red384 instrument at the Department of Health and Human Services Food and Drug Administration (FDA) in Silver Spring, Maryland. The prime contractor is Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions for the biopharmaceutical and life sciences industries. The contract has a firm fixed price of $182,702.00...
- The Food and Drug Administration (FDA) awarded a $16,359 firm fixed-price purchase order to Sartorius Corporation for preventive maintenance and repair services on an IncuCyte S3 Cell Imager at the FDA's facility in Silver Spring, Maryland. The contract, awarded on August 31, 2022, has an ultimate completion date of August 31, 2023, with no set-aside designation. Sartorius Corporation, a subsidiary of German multinational Sartorius Aktiengesellschaft, is a specialized provider of laboratory...
- This is a Firm Fixed Price contract awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The $15,656.00 contract is for preventive maintenance and repair services on a Sartorius Incucyte S3 live-cell analysis system. The contract has a period of performance through September 27, 2025 and was awarded on September...
- The Food and Drug Administration (FDA) awarded a $182,088.32 firm fixed-price purchase order to Sartorius Corporation for preventative maintenance services on seven Sartorius water purification units, with a base period plus two-year option extending through July 2, 2027. The contract was awarded on July 3, 2024, without a set-aside designation. Work will be performed at the FDA's location in Bothell, Washington. Sartorius Corporation, a subsidiary of German multinational Sartorius...
- The U.S. Department of Health and Human Services Food and Drug Administration awarded Sartorius Corporation a $17,176 firm fixed price purchase order for a 12-month service maintenance agreement on an IncuCyte S3 Live-Cell Analysis System located in Silver Spring, Maryland. Under the agreement, Sartorius Corporation Division, a subsidiary of Sartorius Aktiengesellschaft, will provide preventative maintenance services for the cell analysis equipment serial number IC51862 through September 2024....
- This is a firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Sartorius Corporation, a foreign-owned manufacturer of laboratory equipment and solutions. The $20,590 contract is for a maintenance agreement for an Octet R4 instrument, which is a live-cell analysis system used in biomedical research and development. The contract has a period of performance through November 3, 2025. Sartorius...
- The U.S. Food and Drug Administration awarded a $15,656 firm fixed-price purchase order to Sartorius Corporation on June 1, 2024, for preventive maintenance and repair services on an Essen Biosciences IncuCyte S3 live-cell imager (Serial No. IC50633) located in Bohemia, New York. The contract, which carries no set-aside designation, is scheduled for completion by September 23, 2025. Sartorius Corporation, a German-owned manufacturer of laboratory equipment headquartered in Bohemia, New York,...
- This federal contract award was issued by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Sartorius Stedim North America Inc., a subsidiary of the German company Sartorius Aktiengesellschaft. The $89,489.60 Firm Fixed Price Purchase Order is for the supply of bioreactor parts and accessories. The contract does not have a set-aside designation. Sartorius Stedim North America Inc. is a leading provider of laboratory...
- The Food and Drug Administration awarded a $86.8K firm fixed-price purchase order to Sartorius Stedim North America Inc. for operational parts and software updates to Biostat B-DCU II bioprocess control units equipped with BioPat analytics systems. The contract, awarded on September 17, 2019, with a completion date of January 30, 2020, represents a non-set-aside procurement for specialized biopharmaceutical manufacturing support equipment. Sartorius Stedim North America Inc., a subsidiary of...
- The Department of Health and Human Services Food and Drug Administration has awarded a firm fixed price purchase order to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft, to provide an AMBR15 analysis module equipped with BioPAT Spectro hardware and flow cell. The contract has a potential value of $90,507.50 and a completion date of November 17, 2023. No set-aside designation was used for this award. Sartorius Stedim North America Inc. is a...